Lower fasting blood glucose in neurofibromatosis type 1
Open Access
- 1 January 2016
- journal article
- Published by Bioscientifica in Endocrine Connections
- Vol. 5 (1) , 28-33
Abstract
Studies indicate a lower occurrence of diabetes mellitus (DM) in patients with neurofibromatosis type 1 (NF1). Fasting blood glucose (FBG) level is the main criterion used to diagnose DM and glucose intolerance. Therefore, this study compared FBG level between adults with NF1 and non-NF1 controls. We selected clinical records of 57 out of 701 individuals attending the Neurofibromatosis Outpatient Reference Center of the Clinics Hospital of the Federal University of Minas Gerais in Brazil. The selected patients with NF1 were matched to non-NF1 controls selected from the Brazilian Longitudinal Study of Adult Health according to sex, age (range, 35–74 years) and BMI at a ratio of 1:3. In both groups, individuals with DM were excluded. Median FBG level in the NF1 group (86 mg/dl (range, 56–127 mg/dl)) was lower than that in the non-NF1 control group (102 mg/dl (range, 85–146 mg/dl)) (PPP<0.05). In conclusion, adults with NF1 showed a lower FBG level and a lower prevalence of high FBG level compared with non-NF1 controls.Keywords
This publication has 33 references indexed in Scilit:
- Non-invasive endothelial function assessment in patients with neurofibromatosis type 1: a cross-sectional studyBMC Cardiovascular Disorders, 2013
- Neurofibromatosis type 1: from genotype to phenotypeJournal of Medical Genetics, 2012
- Brazilian Longitudinal Study of Adult Health (ELSA-Brasil): Objectives and DesignAmerican Journal of Epidemiology, 2012
- Visfatin in overweight/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome and cardiovascular diseases: a meta‐analysis and systemic reviewDiabetes/Metabolism Research and Reviews, 2011
- Mortality associated with neurofibromatosis type 1: A study based on Italian death certificates (1995-2006)Orphanet Journal of Rare Diseases, 2011
- Standards of Medical Care in Diabetes—2010Diabetes Care, 2010
- Neurofibromatosis type 1 is a disorder of dysplasia: The importance of distinguishing features, consequences, and complicationsBirth Defects Research Part A: Clinical and Molecular Teratology, 2009
- Neurofibromin regulates somatic growth through the hypothalamic–pituitary axisHuman Molecular Genetics, 2008
- Comparison of Body Mass Index, Waist Circumference, and Waist/Hip Ratio in Predicting Incident Diabetes: A Meta-AnalysisEpidemiologic Reviews, 2007
- Mortality in Neurofibromatosis 1: An Analysis Using U.S. Death CertificatesThe American Journal of Human Genetics, 2001